H. influenzae infections not tied to worse outcomes for CF adults

Infection with an airway bacterium called Haemophilus influenzae isn’t linked with worse lung health outcomes among adults with cystic fibrosis (CF), a study suggests. “Our study is the first to specifically dissect the natural history and consequences of H. influenzae infection in adult [people with] CF,” the researchers wrote. The…

When Life Forces You to Pause, It’s Best Not to Argue

If I’m being completely honest — and when I started this column, that was one of my initial promises and intentions — I’ve been struggling lately. But complete honesty doesn’t automatically equal complete transparency, and grief is an emotion so wholly personal and raw I still don’t feel…

Passage of New Antibiotics Bill Is the Goal of March on the Hill Advocates

More than 160 cystic fibrosis (CF) patients representing 46 states met virtually with congressional lawmakers to advocate for legislation that would provide a more robust antibiotics pipeline. As part of the Cystic Fibrosis Foundation’s (CFF) 15th annual March on the Hill, advocates sought sponsorship support for the…

Antabio Wins $2.8 Million Public-Private Partnership Grant to Keep Developing Drug-Resistant Infection Therapy

A U.S. government-backed initiative against drug-resistant bacteria has awarded Antabio $2.8 million to continue developing treatments for Pseudomonas, the most common infection in cystic fibrosis (CF). The grant came from a public-private partnership known as CARB-X, which stands for Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator. CARB-X, formed in July 2016,…